Melanoma Clinical Trials in Massachusetts

Showing 101-120 of 120 trials

Investigation of a Behavioral Substitute for Sunbathing

NCT00403377

RATIONALE: Understanding why sunbathers use or don't use sunless tanning products may help doctors plan effective ways to prevent skin cancer caused by sunbathing. PURPOSE: This phase I/II trial is studying attitudes about the use of sunless tanning products and how well sunless tanning products work as a substitute for sunbathing in healthy participants.

Melanoma (Skin)Skin Cancer

University of Massachusetts, Worcester307 participantsStarted Apr 2006

Worcester, Massachusetts, United States

COMPLETEDPHASE222 miles

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

NCT00026520

RATIONALE: Interferon alfa may interfere with the growth of cancer cells and slow the growth of the tumor. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. Combining interferon alfa with thalidomide may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining interferon alfa with thalidomide in treating patients who have stage IV melanoma.

Melanoma (Skin)

SWOG Cancer Research NetworkStarted Nov 2001

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +91 more locations

Investigation of a Behavioral Substitute for Sunbathing

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Melanoma Trials in Other Cities

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma

Phase II, 2nd Line Melanoma - RAND Monotherapy

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Study of CP-675,206 in Refractory Melanoma

A Study of Volociximab in Metastatic Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

SciBase International Melanoma Pivotal Study

Other Conditions in Massachusetts